Everhart Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $837K | Sell |
1,881
-328
| -15% | -$146K | 0.1% | 147 |
|
|
2025
Q1 | $1.07M | Buy |
2,209
+553
| +33% | +$268K | 0.15% | 100 |
|
|
2024
Q4 | $667K | Sell |
1,656
-480
| -22% | -$193K | 0.14% | 150 |
|
|
2024
Q3 | $993K | Buy |
2,136
+617
| +41% | +$287K | 0.22% | 102 |
|
|
2024
Q2 | $712K | Buy |
1,519
+214
| +16% | +$100K | 0.18% | 115 |
|
|
2024
Q1 | $546K | Buy |
1,305
+138
| +12% | +$57.7K | 0.16% | 137 |
|
|
2023
Q4 | $475K | Buy |
1,167
+53
| +5% | +$21.6K | 0.17% | 118 |
|
|
2023
Q3 | $387K | Buy |
1,114
+105
| +10% | +$36.5K | 0.16% | 118 |
|
|
2023
Q2 | $355K | Buy |
1,009
+84
| +9% | +$29.6K | 0.15% | 137 |
|
|
2023
Q1 | $291K | Buy |
925
+120
| +15% | +$37.8K | 0.13% | 142 |
|
|
2022
Q4 | $232K | Sell |
805
-338
| -30% | -$97.6K | 0.12% | 154 |
|
|
2022
Q3 | $331K | Buy |
1,143
+77
| +7% | +$22.3K | 0.18% | 110 |
|
|
2022
Q2 | $300K | Buy |
+1,066
| New | +$300K | 0.18% | 120 |
|